Valuation: DIAGNOS Inc.

Market Cap 28.9M 20.35M 17.81M 16.44M 15.34M 1.92B 29.42M 197M 76.57M 949M 76.45M 74.75M 3.31B P/E 2025
-6.18x
P/E 2026 -6.51x
Enterprise Value 28.37M 19.98M 17.49M 16.14M 15.06M 1.89B 28.88M 194M 75.18M 932M 75.07M 73.39M 3.25B EV / Sales 2025
293x
EV / Sales 2026 498x
Free-Float
88.96%
Yield 2025 *
-
Yield 2026 -
1 day+6.25%
1 week+10.87%
Current month+10.87%
1 month+10.87%
3 months-7.27%
6 months-27.14%
Current year-32.00%
1 week 0.22
Extreme 0.215
0.26
1 month 0.18
Extreme 0.185
0.26
Current year 0.18
Extreme 0.175
0.38
1 year 0.18
Extreme 0.175
0.42
3 years 0.18
Extreme 0.175
0.59
5 years 0.12
Extreme 0.125
0.6
10 years 0.1
Extreme 0.1
2
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 01/05/2008
Chief Operating Officer - 16/01/2024
Director TitleAgeSince
Director/Board Member - 21/09/2000
Chairman 69 30/10/2025
Director/Board Member 72 28/09/2020
Date Insider Type Main position Quantity % Market Cap.
06-11Option

Director

250,000 0.2076%
06-11Option

Director

250,000 0.2076%
06-11Option

Chief Executive Officer

300,000 0.2491%
Change 5-day change 1-year change 3-year change Capi.($)
+6.25%+10.87%+34.21%-34.62% 20.34M
+0.45%+5.39%-5.28%+108.66% 261B
+0.47%+9.68%+12.94%+43.61% 87.22B
-3.17%-4.53%-40.96%-36.82% 80.28B
-1.18%-3.12%-58.83%-60.12% 76.33B
+0.25%+0.77%-39.90%-9.73% 55.09B
-3.50%-6.10%-37.79%-22.65% 44.38B
-1.10%+1.85%-6.21%+73.22% 35.17B
-2.78%-5.19%-37.81%-8.41% 31.55B
-3.01%+4.61%-6.32%+182.54% 33.15B
Average -0.75%+3.23%-18.60%+23.57% 70.45B
Weighted average by Cap. -0.82%+4.90%-19.20%+44.67%

Financials

2025 2026
Net sales 104K 73.09K 63.98K 59.06K 55.09K 6.91M 106K 708K 275K 3.41M 275K 268K 11.88M 65.48K 46.11K 40.36K 37.26K 34.75K 4.36M 66.65K 447K 173K 2.15M 173K 169K 7.49M
Net income -4.29M -3.02M -2.64M -2.44M -2.27M -285M -4.36M -29.25M -11.36M -141M -11.34M -11.09M -491M -4.56M -3.21M -2.81M -2.59M -2.42M -303M -4.64M -31.09M -12.07M -150M -12.05M -11.78M -521M
Net Debt -164K -115K -101K -93.14K -86.88K -10.9M -167K -1.12M -434K -5.38M -433K -423K -18.74M -525K -370K -324K -299K -279K -34.96M -535K -3.58M -1.39M -17.25M -1.39M -1.36M -60.11M
Logo DIAGNOS Inc.
Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
Employees
22
Date Price Change Volume
30/06/26 CA$0.2550 +6.25% 47,550
29/06/26 CA$0.2400 +2.13% 171,500
26/06/26 CA$0.2350 +4.44% 150,500
25/06/26 CA$0.2250 -1.10% 140,400
24/06/26 CA$0.2275 -1.09% 64,342

Annual profits - Rate of surprise